专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2009040029A3 USE OF ADRENOMEDULLIN AS A THERAPEUTIC AGENT FOR THE TREATMENT OF EXCESSIVE ANGIOGENESIS 审中-公开
标题翻译：将ADRENOMEDULLIN用作治疗过敏原血症的治疗药物
公开(公告)号：WO2009040029A3
公开(公告)日：2009-12-17
申请号：PCT/EP2008007738
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/12 , A61K38/22 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/22 , A61P35/00 , A61P37/00
CPC分类号： A61K38/2242 , A23L33/18 , A23L33/40 , A23V2002/00 , A61K38/2235 , A61K2300/00 , A23V2200/308 , A23V2200/318 , A23V2200/322 , A23V2200/324 , A23V2200/326 , A23V2250/55
摘要： The present invention is directed to the use of the peptide compound Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-lle-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-lle-Ser-Pro-Gln-Gly-Tyr-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-lle-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-lle-Ser-Pro-Gln-Gly-Tyr-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly- THR-CYS-THR-VAL-GLN-赖氨酸-LEU-ALA-他-GLN-LLE-酪氨酸 - 谷氨酰胺，苯丙氨酸，苏氨酸，天冬氨酸 - 赖氨酸 - 天冬氨酸 - 赖氨酸 - 天冬氨酸-ASN-VAL-ALA-Pro的-Arg- Ser-Lys-Lle-Ser-Pro-Gln-Gly-Tyr-NH2作为预防和/或治疗癌症，自身免疫疾病，纤维化疾病，炎性疾病，神经变性疾病，传染病，肺部疾病，心脏和血管疾病和代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly- 亮 - 精 - 为Ser-Phe - 甘氨酸 - 半胱氨酸 - 精氨酸，苯丙氨酸，甘氨酸，苏氨酸，半胱氨酸，苏氨酸，缬氨酸，谷氨酰胺，赖氨酸，亮氨酸，丙氨酸 - 他-GLN-LLE-酪氨酸 - 谷氨酰胺，苯丙氨酸，苏氨酸，Asp-的 Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-1le-Ser-Pro-Gln-Gly-Tyr-NH 2任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂。

2. 发明申请

WO2009040028A3 USE OF CASOXIN C AND OPTIONALLY ADRENOMEDULLIN AS THERAPEUTIC AGENTS FOR THE TREATMENT OF EXCESSIVE ANGIOGENESIS 审中-公开
标题翻译：用于治疗过敏原性的治疗药物的CASOXIN C和OPORALY ADRENOMEDULLIN的使用
公开(公告)号：WO2009040028A3
公开(公告)日：2009-12-17
申请号：PCT/EP2008007737
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/01 , A61K38/22 , A61K38/55 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00
CPC分类号： A61K38/1709 , A23C9/1526 , A23L33/18 , A23L33/40 , A61K38/08 , A61K2300/00
摘要： The present invention is directed to the use of the peptide compound Tyr-lle-Pro-lle-Gln-Tyr-Val-Leu-Ser-Arg-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Tyr-lle-Pro-lle-Gln-Tyr-Val-Leu-Ser-Arg-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Tyr-Lle-Pro-lle-Gln-Tyr-Val-Leu-Ser-Arg-OH作为预防和/或治疗癌症，自身免疫疾病，纤维化疾病，炎性疾病，神经变性疾病，传染病，肺部疾病，心脏和血管疾病以及代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有Tyr-Ile-Pro-Ile-Gln-Tyr-Val-Leu-Ser-Arg- OH任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起。

3. 发明申请

WO2009039968A3 USE OF ANGIOTENSIN III AS A THERAPEUTIC AGENT IN THE TREATMENT OF EG HBV INFECTION 审中-公开
标题翻译：作为治疗乙肝感染治疗药物的血管紧张素III的使用
公开(公告)号：WO2009039968A3
公开(公告)日：2009-12-17
申请号：PCT/EP2008007510
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/08 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/06 , A61P31/18 , A61P31/20 , A61P35/00 , A61P37/00
CPC分类号： A61K38/085 , A61K38/35
摘要： The present invention is directed to the use of the peptide compound Arg-Val-Tyr-lle- His-Pro-Phe-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Arg-Val-Tyr-lle-His-Pro-Phe-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Arg-Val-Tyr-Ile-His-Pro-Phe-OH作为预防和/或治疗癌症，自身免疫性疾病，纤维化疾病，炎性疾病，神经变性疾病，传染病，肺部疾病，心脏和血管疾病以及代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有Arg-Val-Tyr-Ile-His-Pro-Phe-OH的母乳代用品的药物组合物，一种药学上可接受的载体，低温保护剂，冻干保护剂，赋形剂和/或稀释剂。

4. 发明申请

WO2009039966A3 USE OF NF-KAPPAB INHIBITOR SN50 AND OPTIONALLY ANGIOTENSIN III AS THERAPEUTIC AGENTS IN THE TREATMENT OF EG HBV INFECTION 审中-公开
标题翻译：使用NF-KAPPAB抑制剂SN50和可溶性血管紧张素II作为治疗乙肝感染的治疗药物
公开(公告)号：WO2009039966A3
公开(公告)日：2009-12-17
申请号：PCT/EP2008007500
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/17 , A61K38/08 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/06 , A61P31/18 , A61P31/20 , A61P35/00 , A61P37/00
CPC分类号： A61K38/12 , A61K2300/00
摘要： The present invention is directed to the use of the peptide compound AIa-AIa-VaI-AIa- Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu- Met-Pro-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu- Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物AIa-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg- Lys-Arg-Gln-Lys-Leu- Met-Pro-OH作为预防和/或治疗癌症，自身免疫性疾病，纤维化疾病，炎性疾病，神经变性疾病，感染性疾病，肺部疾病，心脏和血管的治疗剂疾病和代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu- Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-OH任选地与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/ 或稀释剂。

5. 发明申请

WO2009040024A3 USE OF BIM-23127 AND OPTIONALLY URODILATIN AS THERAPEUTIC AGENTS EG FOR THE TREATMENT OF M. TUBERCULOSIS INFECTIONS 审中-公开
标题翻译：使用BIM-23127和作为治疗药物EG的治疗方案，用于治疗M.TUBCCOSOSIS感染
公开(公告)号：WO2009040024A3
公开(公告)日：2009-11-26
申请号：PCT/EP2008007718
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/22 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/04 , A61P31/06 , A61P31/20 , A61P35/00 , A61P37/00
CPC分类号： A61K38/11
摘要： The present invention is directed to the use of the peptide compound D-2-Nal-Cys-Tyr- D-Trp-0m-Val-Cys-2-Nal-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide D-2-Nal-Cys-Tyr-D-Trp-Orn-Val-Cys-2- NaI-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物D-2-Nal-Cys-Tyr-D-Trp-0m-Val-Cys-2-Nal-NH 2作为预防和/或治疗癌症的治疗剂，自身免疫性疾病，纤维化疾病，炎症性疾病，神经变性疾病，感染性疾病，肺部疾病，心脏和血管疾病以及代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有D-2-Nal-Cys-Tyr-D-Trp-Orn-Val-Cys- 2- NaI-NH 2任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起。

6. 发明申请

WO2009033782A3 USE OF A TEPROTIDE AND OPTIONALLY CARBETOCIN TO TREAT EG AIDS OR IDIOPATHIC PULMONAY FIBROSIS 审中-公开
标题翻译：使用TEPROTIDE和OPENTALLY CARBETOCIN治疗艾滋病或多发性肺栓塞病
公开(公告)号：WO2009033782A3
公开(公告)日：2009-11-26
申请号：PCT/EP2008007966
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/55 , A61K38/08 , A61K38/11 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/06 , A61P31/18 , A61P31/20 , A61P35/00 , A61P37/00
CPC分类号： A61K38/08 , A61K38/11 , A61K2300/00
摘要： The present invention is directed to the use of the peptide compound Pyr-Trp-Pro-Arg- Pro-Gln-Ile-Pro-Pro-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH作为预防和/或治疗癌症，自身免疫疾病，纤维化疾病的治疗剂的用途炎性疾病，神经变性疾病，传染病，肺部疾病，心脏和血管疾病以及代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有Phe-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH的母乳替代物的药物组合物，以及至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂。

7. 发明申请

WO2009033750A3 USE OF PHM-27 ALONE OR IN COMBINATION WITH LEU-ENKEPHALIN AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用PHM-27单独或与LEE-ENKEPHALIN组合作为治疗剂
公开(公告)号：WO2009033750A3
公开(公告)日：2009-11-12
申请号：PCT/EP2008007798
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/22 , A61K38/33 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00
CPC分类号： A61K38/09 , A61K38/33 , A61K2300/00
摘要： The present invention is directed to the use of the peptide compound His-Ala-Asp-Gly- Val-Phe-Thr-Ser-Asp-Phe-Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu- Ser-Leu-Met-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp- Phe-Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala- Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-NH2作为预防和/或治疗癌症，自身免疫性疾病，纤维化疾病，炎症性疾病，神经变性疾病，传染病，肺部疾病，心脏和血管疾病和代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe- Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-NH2任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂。

8. 发明申请

WO2009033711A3 USE OF GLP-1 AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用GLP-1作为治疗剂
公开(公告)号：WO2009033711A3
公开(公告)日：2009-11-12
申请号：PCT/EP2008007573
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/26 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/20 , A61P35/00 , A61P37/00
CPC分类号： A61K38/22 , A23L33/18 , A23L33/40 , A23V2002/00 , A61K38/26 , A61K2300/00 , A23V2200/308 , A23V2200/318 , A23V2200/322 , A23V2200/324 , A23V2200/326 , A23V2250/55
摘要： The present invention is directed to the use of the peptide compound His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-lle-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-lle-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr- Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ala-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH作为预防和/ ，自身免疫性疾病，纤维化疾病，炎症性疾病，神经变性疾病，感染性疾病，肺部疾病，心脏和血管疾病以及代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有肽His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly- 苏氨酸 - 苯丙氨酸 - 苏氨酸 - 丝氨酸 - 天冬氨酸 - 缬氨酸 - 丝氨酸 - 丝氨酸 - 酪氨酸 - 亮氨酸 - 谷氨酸 - 甘氨酸 - 谷氨酰胺 - 丙氨酸 - 丙氨酸 - 赖氨酸的Glu-PHE-LLE-ALA-TRP-LEU-缬氨酸 - 赖氨酸 - Gly- Arg-Gly-OH任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起。

9. 发明申请

WO2009033819A3 USE OF GLICENTIN-RELATED POLYPEPTIDE AND APELIN- 13 IN COMBINATION AS THERAPEUTIC AGENTS, EG FOR TREATING AIDS 审中-公开
标题翻译：作为治疗药物组合使用与玻璃体相关的多肽和APELIN-13作为治疗艾滋病的EG
公开(公告)号：WO2009033819A3
公开(公告)日：2009-11-05
申请号：PCT/EP2008008187
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/17 , A61K38/26 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/18 , A61P35/00 , A61P37/00
CPC分类号： A61K38/1709 , A61K38/26 , A61K2300/00
摘要： The present invention is directed to the use of the combination of the peptide compounds Arg-Ser-Leu-Gln-Asp-Thr-Glu-Glu-Lys-Ser-Arg-Ser-Phe-Ser-Ala-Ser- Gln-Ala-Asp-Pro-Leu-Ser-Asp-Pro-Asp-Gln-Met-Asn-Glu-Asp-OH and Gln-Arg-Pro- Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease.
摘要翻译：本发明涉及肽化合物Arg-Ser-Leu-Gln-Asp-Thr-Glu-Glu-Lys-Ser-Arg-Ser-Phe-Ser-Ala-Ser-Gln-Ala -Asp-Pro-Leu-Ser-Asp-Pro-Asp-Gln-Met-Asn-Glu-Asp-OH和Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro -Phe-OH作为预防和/或治疗癌症，心脏和血管疾病，感染性疾病，纤维化疾病，炎性疾病，神经变性疾病或自身免疫性疾病的治疗组合。

10. 发明申请

WO2009033797A3 USE OF APELIN-17 AND PEPTIDE YY AS THERAPEUTIC AGENTS, EG FOR TREATING HBV INFECTION 审中-公开
标题翻译：使用APELIN-17和肽作为治疗药物，EG用于治疗HBV感染
公开(公告)号：WO2009033797A3
公开(公告)日：2009-11-05
申请号：PCT/EP2008008099
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/17 , A61K38/22 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/20 , A61P35/00 , A61P37/00
CPC分类号： A61K38/22 , A23L33/18 , A23L33/40 , A23V2002/00 , A61K38/26 , A61K2300/00 , A23V2200/308 , A23V2200/318 , A23V2200/322 , A23V2200/324 , A23V2200/326 , A23V2250/55
摘要： The present invention is directed to the use of the combination of the Lys-Phe-Arg- Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH and Tyr-Pro-lle-Lys- Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu- Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease.
摘要翻译：本发明涉及使用Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH和Tyr -Pro-Lle-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu- Arg-His -Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2作为预防和/或治疗癌症，心脏和血管疾病，感染性疾病，纤维化疾病，炎症性疾病，神经变性疾病或自身免疫性疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式